$68.9B
$134 Million
0.07% of portfolio
462
Q4 2024
Reduced 10.29%
$28.7B
$121 Million
0.06% of portfolio
2,115
Q4 2024
Reduced 29.9%
$167B
$118 Million
0.06% of portfolio
2,963
Q4 2024
Reduced 23.1%
$125B
$122 Million
0.06% of portfolio
368
Q2 2023
New
$70B
$114 Million
0.06% of portfolio
434
Q4 2023
Added 40.45%
$0
$115 Million
0.06% of portfolio
270
Q4 2023
Reduced 14.56%
$0
$130 Million
0.06% of portfolio
316
Q2 2023
New
$0
$131 Million
0.06% of portfolio
708
Q3 2024
Added 16.07%
$0
$125 Million
0.06% of portfolio
984
Q4 2024
Reduced 4.47%
$66.6B
$119 Million
0.06% of portfolio
422
Q1 2024
Reduced 8.66%
$0
$118 Million
0.06% of portfolio
3,739
Q4 2023
Reduced 3.66%
$68.5B
$123 Million
0.06% of portfolio
3,800
Q2 2023
New
$70.9B
$123 Million
0.06% of portfolio
2,736
Q4 2024
Reduced 44.08%
$112B
$130 Million
0.06% of portfolio
471
Q3 2024
Reduced 12.13%
$45.5B
$105 Million
0.05% of portfolio
1,945
Q3 2024
Added 9.89%
$43.3M
$104 Million
0.05% of portfolio
25,863
Q1 2024
Reduced 50.0%
$12B
$104 Million
0.05% of portfolio
505
Q2 2023
New
$0
$98 Million
0.05% of portfolio
1,100
Q4 2023
Reduced 0.45%
$86.5B
$96.8 Million
0.05% of portfolio
1,279
Q4 2024
Reduced 7.25%
$41.7B
$104 Million
0.05% of portfolio
1,230
Q3 2024
Added 173.33%
$158B
$104 Million
0.05% of portfolio
1,475
Q3 2024
Reduced 7.23%
$0
$96.1 Million
0.05% of portfolio
620
Q3 2024
Reduced 26.45%
$0
$104 Million
0.05% of portfolio
583
Q2 2023
New
$0
$94 Million
0.05% of portfolio
419
Q2 2023
New
$0
$93.7 Million
0.05% of portfolio
256
Q4 2024
Added 34.74%
$82.5B
$91.7 Million
0.05% of portfolio
727
Q4 2024
Reduced 11.88%
$72B
$95 Million
0.05% of portfolio
75
Q2 2023
New
$0
$106 Million
0.05% of portfolio
1,407
Q2 2024
Reduced 36.25%
$113B
$109 Million
0.05% of portfolio
512
Q3 2024
Added 2.2%
$65.6B
$89.4 Million
0.04% of portfolio
394
Q2 2023
New
$0
$86.8 Million
0.04% of portfolio
1,114
Q2 2023
New
$85B
$87.7 Million
0.04% of portfolio
93
Q2 2023
New
$52.9B
$88.3 Million
0.04% of portfolio
2,475
Q2 2023
New
$235B
$78.2 Million
0.04% of portfolio
1,249
Q3 2024
Reduced 12.6%
$0
$84.1 Million
0.04% of portfolio
1,000
Q2 2024
Reduced 10.87%
$34.1B
$80.9 Million
0.04% of portfolio
907
Q2 2023
New
$38B
$89.4 Million
0.04% of portfolio
1,173
Q3 2024
Reduced 9.7%
$0
$86 Million
0.04% of portfolio
1,479
Q1 2024
Added 136.64%
$0
$82.5 Million
0.04% of portfolio
600
Q2 2023
New
$53.7B
$76.7 Million
0.04% of portfolio
1,124
Q1 2024
Reduced 4.26%
$0
$79 Million
0.04% of portfolio
293
Q4 2024
Added 19.11%
$275B
$87.9 Million
0.04% of portfolio
973
Q3 2024
Added 11.45%
Glaxo Smithkline PLC Adr New
-
$85 Million
0.04% of portfolio
-
Q4 2024
Reduced 6.26%
$237B
$81.6 Million
0.04% of portfolio
649
Q3 2024
Added 30.06%
$0
$83.5 Million
0.04% of portfolio
1,019
Q4 2024
Reduced 55.09%
$306B
$90.8 Million
0.04% of portfolio
1,293
Q1 2024
Reduced 7.84%
$0
$72.2 Million
0.04% of portfolio
251
Q4 2024
Reduced 13.15%
$5.59B
$82 Million
0.04% of portfolio
750
Q2 2023
New
$22.2B
$86.4 Million
0.04% of portfolio
3,070
Q4 2024
Reduced 7.28%
-
$90.3 Million
0.04% of portfolio
-
Q4 2024
New